Judge OKs Aphton Sale Of Cancer Drug
A bankruptcy judge has signed off on a deal that will allow biopharmaceutical company Aphton Corp. to sell off its gastrointestinal cancer drug to Receptor BioLogix Inc....To view the full article, register now.
Already a subscriber? Click here to view full article